BridgeBio Pharma annual gross margin
2021
2022
2023
2024
2025
BridgeBio Pharma Gross Margin Growth & History (BBIO)
BridgeBio Pharma's gross margin was 95.82% for fiscal 2025.
View full BridgeBio Pharma company overviewBridgeBio Pharma annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 95.82% | −2.43 pp |
| 2024 | 2024-12-31 | 98.25% | +24.54 pp |
| 2023 | 2023-12-31 | 73.71% | −21.87 pp |
| 2022 | 2022-12-31 | 95.58% | +0.04 pp |
| 2021 | 2021-12-31 | 95.53% | — |
BridgeBio Pharma quarterly gross margin
Q3.20
Q2.21
Q3.21
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 93.83% | −2.87 pp |
| Q1 2026 | 2026-03-31 | 94.89% | −2.85 pp |
| Q4 2025 | 2025-12-31 | 94.74% | +30.17 pp |
| Q3 2025 | 2025-09-30 | 94.56% | +16.45 pp |
| Q2 2025 | 2025-06-30 | 96.70% | +24.28 pp |
| Q1 2025 | 2025-03-31 | 97.74% | −1.98 pp |
| Q4 2024 | 2024-12-31 | 64.57% | −1.16 pp |
| Q3 2024 | 2024-09-30 | 78.11% | −7.27 pp |
| Q2 2024 | 2024-06-30 | 72.42% | +8.92 pp |
| Q1 2024 | 2024-03-31 | 99.72% | +35.37 pp |
| Q4 2023 | 2023-12-31 | 65.73% | — |
| Q3 2023 | 2023-09-30 | 85.38% | +204.02 pp |
| Q2 2023 | 2023-06-30 | 63.50% | −35.55 pp |
| Q1 2023 | 2023-03-31 | 64.35% | — |
| Q3 2022 | 2022-09-30 | −118.64% | −156.61 pp |
| Q2 2022 | 2022-06-30 | 99.05% | −0.75 pp |
| Q3 2021 | 2021-09-30 | 37.97% | −62.03 pp |
| Q2 2021 | 2021-06-30 | 99.80% | — |
| Q3 2020 | 2020-09-30 | 100.00% | — |
BridgeBio Pharma gross margin trends
Between the periods ended 2021-12-31 and 2025-12-31, BridgeBio Pharma's gross margin increased from 95.53% to 95.82%, a change of +0.29 percentage points. The latest reported quarter, Q2 2026, shows 93.83%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BridgeBio Pharma source filings ↗Community posts
BridgeBio’s Attruby sales expand as a one-time milestone boosts quarterly revenue
BridgeBio ($BBIO) reported third-quarter 2026 revenue of $353.2 million, compared with $120.7 million a year earlier. US Attruby sales reached $253.2 million, increasing approximately $31 million sequentially and $145 million year over year ...
